{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T20:38:44Z","timestamp":1781383124600,"version":"3.54.1"},"reference-count":44,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,11,29]]},"DOI":"10.1536\/ihj.21-246","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T22:13:25Z","timestamp":1636150405000},"page":"1221-1229","source":"Crossref","is-referenced-by-count":21,"title":["High-Sensitivity C-Reactive Protein to HDL-C Ratio"],"prefix":"10.1536","volume":"62","author":[{"given":"Haorou","family":"Luo","sequence":"first","affiliation":[{"name":"School of Medicine, University of Electronic Science and Technology of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuli","family":"Kou","sequence":"additional","affiliation":[{"name":"School of Medicine, Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixue","family":"Yin","sequence":"additional","affiliation":[{"name":"Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17: 1410-22.","DOI":"10.1038\/nm.2538"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhao W, Meng R, Ma C, <i>et al<\/i>. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: A proof-of-concept, randomized controlled trial. Circulation 2017; 135: 1325-35.","DOI":"10.1161\/CIRCULATIONAHA.116.024807"},{"key":"3","unstructured":"3. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease--the Framingham heart study. Can J Cardiol 1988; 4: 5A-10A."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Xu L, Zhao G, Wang J, <i>et al<\/i>. Impact of genetic variation in aldehyde dehydrogenase 2 and alcohol consumption on coronary artery lesions in Chinese patients with stable coronary artery disease. Int Heart J 2018; 59: 689-94.","DOI":"10.1536\/ihj.17-165"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yu C, Wan Y, Xu W, <i>et al<\/i>. Increased circulating cathepsin L in patients with coronary artery disease. Int Heart J 2021; 62: 9-15.","DOI":"10.1536\/ihj.20-182"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. He P, Fan SY, Guan JQ, <i>et al<\/i>. Mediation analysis for the relationship between dyslipidemia and coronary artery disease via hypersensitive C-reactive protein in a case-control study. Coron Artery Dis 2020; 31: 613-9.","DOI":"10.1097\/MCA.0000000000000911"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Park JJ, Jang HJ, Oh IY, <i>et al<\/i>. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2013; 111: 636-42.","DOI":"10.1016\/j.amjcard.2012.11.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. S\u00f6nmez O, Erta\u015f G, Bacaks\u0131z A, <i>et al<\/i>. Relation of neutrophil-to-lymphocyte ratio with the presence and complexity of coronary artery disease: an observational study. Anadolu Kardiyol Derg 2013; 13: 662-7.","DOI":"10.5152\/akd.2013.188"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kou T, Luo H, Yin L. Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis. BMC Cardiovasc Disord 2021; 21: 127.","DOI":"10.1186\/s12872-020-01771-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Montorsi P, Ravagnani PM, Galli S, <i>et al<\/i>. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006; 27: 2632-9.","DOI":"10.1093\/eurheartj\/ehl142"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Duan L, Liu C, Hu J, <i>et al<\/i>. Epigenetic mechanisms in coronary artery disease: the current state and prospects. Trends Cardiovasc Med 2018; 28: 311-9.","DOI":"10.1016\/j.tcm.2017.12.012"},{"key":"12","unstructured":"12. Hao J, Du H, Li WW, <i>et al<\/i>. Effects of atorvastatin combined with trimetazidine on myocardial injury and inflammatory mediator in unstable angina patients during perioperative of percutaneous coronary intervention. Eur Rev Med Pharmacol Sci 2015; 19: 4642-6."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Huang A, Qi X, Wei L, Zhang M, Zhou S. Non-HDL-c\/TC: A Novel Lipid-Related Marker in the Assessment of Severity of Coronary Artery Lesions and Cardiovascular Outcomes. Cardiol Res Pract 2019; 2019: 5931975.","DOI":"10.1155\/2019\/5931975"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cheng G, Chang FJ, Wang Y, <i>et al<\/i>. Factors influencing stent restenosis after percutaneous coronary intervention in patients with coronary heart disease: A clinical trial based on 1-year follow-up. Med Sci Monit 2019; 25: 240-7.","DOI":"10.12659\/MSM.908692"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mor-Avi V, Patel MB, Maffessanti F, <i>et al<\/i>. Fusion of three-dimensional echocardiographic regional myocardial strain with cardiac computed tomography for noninvasive evaluation of the hemodynamic impact of coronary stenosis in patients with chest pain. J Am Soc Echocardiogr 2018; 31: 664-73.","DOI":"10.1016\/j.echo.2018.01.019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ling P, Shan W, Zhai G, <i>et al<\/i>. Association between glutathione peroxidase-3 activity and carotid atherosclerosis in patients with type 2 diabetes mellitus. Brain Behav 2020; 10: e01773.","DOI":"10.1002\/brb3.1773"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yang H, Young D, Gao J, <i>et al<\/i>. Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China. Lipids Health Dis 2019; 18: 18.","DOI":"10.1186\/s12944-019-0970-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Namazi MR, Parhizkar AR, Jowkar F. Serum levels of hypersensitive-C-reactive protein in moderate and severe acne. Indian Dermatol Online J 2015; 6: 253-7.","DOI":"10.4103\/2229-5178.160256"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhang LY, Ma XY, Lin J, <i>et al<\/i>. Prevalence and risk factors of restless legs syndrome in hemodialysis patients. Nat Sci Sleep 2020; 12: 19-27.","DOI":"10.2147\/NSS.S236393"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wang L, Duan J, Bian T, <i>et al<\/i>. Inflammation is correlated with severity and outcome of cerebral venous thrombosis. J Neuroinflammation 2018; 15: 329.","DOI":"10.1186\/s12974-018-1369-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zhang S, Chen L, Zhou Z, Fan W, Liu S. Effects of puerarin on clinical parameters, vascular endothelial function, and inflammatory factors in patients with coronary artery disease. Med Sci Monit 2019; 25: 402-8.","DOI":"10.12659\/MSM.911108"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yuan SM, Shi YH, Wang JJ, L\u00fc FQ, Gao S. Elevated plasma D-dimer and hypersensitive C-reactive protein levels may indicate aortic disorders. Rev Bras Cir Cardiovasc 2011; 26: 573-81.","DOI":"10.1590\/S0102-76382011000200006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gao CZ, Ma QQ, Wu J, <i>et al<\/i>. Comparison of the effects of ticagrelor and clopidogrel on inflammatory factors, vascular endothelium functions and short-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention: a pilot study. Cell Physiol Biochem 2018; 48: 385-96.","DOI":"10.1159\/000491768"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pang H, Han B, Li ZY, Fu Q. Identification of molecular markers in patients with hypertensive heart disease accompanied with coronary artery disease. Genet Mol Res 2015; 14: 93-100.","DOI":"10.4238\/2015.January.15.12"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Li S, Pan G, Chen H, Niu X. Determination of serum homocysteine and hypersensitive C-reactive protein and their correlation with premature coronary heart disease. Heart Surg Forum 2019; 22: E215-7.","DOI":"10.1532\/hsf.2223"},{"key":"26","unstructured":"26. Haleem N, Marwat IZ, Tauqeer S, Abbasi S. C reactive protein levels as a marker of coronary heart disease in middle aged individuals. J Ayub Med Coll Abbottabad 2016; 28: 168-71."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Song Y, Yang Y, Zhang J, <i>et al<\/i>. The apoB100\/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography. Lipids Health Dis 2015; 14: 150.","DOI":"10.1186\/s12944-015-0155-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Batuca JR, Amaral MC, Favas C, <i>et al<\/i>. Antibodies against HDL components in ischaemic stroke and coronary artery disease. Thromb Haemost 2018; 118: 1088-100.","DOI":"10.1055\/s-0038-1645857"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Dai W, Zhang Z, Yao C, Zhao S. Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease. Lipids Health Dis 2019; 18: 220.","DOI":"10.1186\/s12944-019-1166-5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Barbosa CJDG, Maranh\u00e3o RC, Barreiros RS, <i>et al<\/i>. Lipid transfer to high-density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events. Clin Cardiol 2019; 42: 1100-5.","DOI":"10.1002\/clc.23259"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Keul P, Polzin A, Kaiser K, <i>et al<\/i>. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy. FASEB J 2019; 33: 1482-95.","DOI":"10.1096\/fj.201801245R"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Heinecke JW. The HDL proteome: a marker--and perhaps mediator--of coronary artery disease. J Lipid Res 2009; 50; Suppl (Suppl): S167-71.","DOI":"10.1194\/jlr.R800097-JLR200"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wang G, Mathew AV, Yu H, <i>et al<\/i>. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease. PLOS ONE 2018; 13: e0193782.","DOI":"10.1371\/journal.pone.0193782"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Rosenson RS, Brewer HB Jr, Ansell BJ, <i>et al<\/i>. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 2016; 13: 48-60.","DOI":"10.1038\/nrcardio.2015.124"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Landmesser U. Coronary artery disease: HDL and coronary heart disease--novel insights. Nat Rev Cardiol 2014; 11: 559-60.","DOI":"10.1038\/nrcardio.2014.128"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Srivastava RAK. Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease. Mol Cell Biochem 2018; 440: 167-87.","DOI":"10.1007\/s11010-017-3165-z"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kosmas CE, Martinez I, Sourlas A, <i>et al<\/i>. High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs Context 2018; 7: 212525.","DOI":"10.7573\/dic.212525"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Asztalos BF, Batista M, Horvath KV, <i>et al<\/i>. Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. Arterioscler Thromb Vasc Biol 2003; 23: 847-52.","DOI":"10.1161\/01.ATV.0000066133.32063.BB"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Landmesser U, Hazen S. HDL-cholesterol, genetics, and coronary artery disease: the myth of the &apos;good cholesterol&apos;? Eur Heart J 2018; 39: 2179-82.","DOI":"10.1093\/eurheartj\/ehy299"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Huang JB, Chen YS, Ji HY, <i>et al<\/i>. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study. Lipids Health Dis 2020; 19: 59.","DOI":"10.1186\/s12944-020-01238-2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Yang Y, Xu Y, Wang J, Zhai X, Jiang H. Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study. BMC Cardiovasc Disord 2020; 20: 500.","DOI":"10.1186\/s12872-020-01773-x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Wada H, Dohi T, Miyauchi K, <i>et al<\/i>. Neutrophil to lymphocyte ratio and long-term cardiovascular outcomes in coronary artery disease patients with low high-sensitivity C-reactive protein level. Int Heart J 2020; 61: 447-53.","DOI":"10.1536\/ihj.19-543"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Nose D, Shiga Y, Ueda Y, <i>et al<\/i>. Association between plasma levels of PCSK9 and the presence of coronary artery disease in Japanese. Heart Vessels 2019; 34: 19-28.","DOI":"10.1007\/s00380-018-1218-1"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Turan T, Mente\u015fe \u00dc, A\u011fa\u00e7 MT, <i>et al<\/i>. The relation between intensity and complexity of coronary artery lesion and oxidative stress in patients with acute coronary syndrome. Anatol J Cardiol 2015; 15: 795-800.","DOI":"10.5152\/akd.2014.5761"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/6\/62_21-246\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T03:40:56Z","timestamp":1638589256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/6\/62_21-246\/_article"}},"subtitle":["A Predictor of Coronary Artery Disease"],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.21-246","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"article-number":"21-246"}}